Find uplifting stories about heroes, innovations, and solutions
2562 results for "melanoma awareness"
After Emily Robertson-Miller died suddenly from melanoma that spread to her brain, her loved ones turned grief into action. The community rallied at Geraldton's 15th Melanoma March, raising thousands for research and awareness.
A man's life was saved by two coincidences: his brother-in-law pointing out a spot on his leg, then stumbling upon a mobile skin cancer screening days later. His story highlights why catching melanoma early makes all the difference.
After decades of careful sun protection, Sherry O'Daniell was devastated to learn childhood sun exposure had given her stage 3 melanoma. Thanks to new immunotherapy treatment, she's now cancer-free and sharing her story to help others.
After surviving stage 1 melanoma at 26, Leah Adams turned her tanning bed past into a powerful mission to protect others. Her story proves it's never too early to take skin cancer seriously.
Dancing with the Stars pro Witney Carson discovered melanoma on her foot at just 19 years old. Her story proves that catching skin cancer early can save your life, with a 99% survival rate when detected in time.
A personalized mRNA cancer vaccine has shown remarkable success in preventing melanoma from returning and spreading in late-stage trials. Thousands of high-risk melanoma patients could benefit as soon as next year if regulators approve the groundbreaking treatment.
University of Texas researchers solved a decade-long puzzle about why melanoma treatments work better when gradually reduced rather than stopped and restarted. Their discovery could help over 112,000 Americans diagnosed with melanoma this year get more effective care with fewer side effects.
Scientists created a heat-activated patch that killed 97% of melanoma lesions in mice without damaging healthy skin. The experimental treatment could one day replace invasive surgery for early-stage skin cancer.
After years of setbacks, a new treatment for advanced melanoma just won FDA approval, giving patients a powerful option when other therapies have failed. The drug could help thousands facing one of the deadliest forms of skin cancer.
Two Australian scientists transformed melanoma from a death sentence into a treatable disease, saving hundreds of lives each year. Their breakthrough immunotherapy approach now gives patients a 55% survival rate where there was once almost no hope.
A groundbreaking Australian-led trial shows personalised mRNA therapy combined with immunotherapy cut melanoma recurrence by 49% in high-risk patients. It's the first late-stage success for personalised cancer vaccines.
After 12 years and multiple melanoma diagnoses, Joe Eastin faced his toughest challenge when the cancer spread to his bones. Cutting-edge immunotherapy shrank his tumor by 50% in just three months.
A groundbreaking cancer therapy now lets doctors turn advanced melanoma tumors into personalized healing machines. The FDA-approved TIL therapy harnesses immune cells from a patient's own tumor to fight back against the disease.
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.
A personalized mRNA vaccine combined with immunotherapy reduced melanoma recurrence or death by nearly half over five years. The breakthrough treatment, developed by Merck and Moderna, teaches the immune system to recognize and attack cancer cells.
A personalized cancer vaccine combined with immunotherapy has kept nearly 70% of melanoma patients cancer-free five years after surgery. The breakthrough offers new hope for preventing one of the deadliest skin cancers from coming back.
A personalized mRNA cancer vaccine just achieved its first major trial success, stopping melanoma from returning in patients who had tumors removed. The breakthrough could launch an entirely new way to fight cancer by 2027.
A personalized cancer vaccine using mRNA technology just helped melanoma patients live longer without their cancer returning. The breakthrough treatment could become the first of its kind approved for cancer care.
A personalized mRNA vaccine combined with immunotherapy stopped melanoma from returning in 69% of patients over five years, nearly double the rate of standard treatment alone. The breakthrough could transform how doctors fight not just skin cancer, but many other cancers too.
A personalized cancer treatment using mRNA technology just passed its first large-scale trial, significantly reducing melanoma recurrence. Experts are calling it a breakthrough moment for cancer care. #
Showing 20 of 2562